For the latest updates on our ongoing response to COVID-19, please click here.

NASH Models of Care RFP

NASH Models of Care Program

Appropriate suspicion, screening, identification, and linkage to care of patients with advanced fibrosis due to NASH remain a significant unmet need. Key success factors for identification of NASH patients and subsequent care delivery includes use of simple noninvasive tests (NITs), standardized referral and treatment algorithms, and multi-disciplinary collaboration between endocrinology/diabetology and hepatology/GI specialists. Gilead seeks to support research projects focused on ways to develop efficient and effective care pathways between multidisciplinary providers in the screening, identification, referral and treatment of high-risk NASH patients.

The NASH Models of Care program aims to fund approximately 8-10 projects worldwide with research grants of up to $500,000 each. Successful projects should demonstrate clear objectives, defined timelines, a scientifically appropriate care pathway plan (i.e., protocol), and proposed data generation which has relevance to the medical community and policy makers.

Additional information about the NASH Models of Care Program is found in the downloadable Request for Applications (RFA) document available in the sidebar.

Key Dates & Program Specifics:

  • Proposals will be initiated with a Letter of Intent (LOI), submitted to
  • LOI should be submitted using the template provided below
    • 03 June 2019: LOI submission window opens
    • 15 July 2019: LOI submission window closes

Questions about the program or application process should be submitted to your local Gilead Medical Scientist or to